hVIVO plc (ISE: HVO)

Ireland flag Ireland · Delayed Price · Currency is EUR
0.320
0.00 (0.00%)
May 17, 2024, 7:00 AM IST
88.24%
Market Cap 217.72M
Revenue 56.04M
Net Income 16.12M
Shares Out 680.37M
EPS 0.02
PE Ratio 13.62
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open 0.320
Previous Close 0.320
Day's Range 0.320 - 0.320
52-Week Range 0.160 - 0.360
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About hVIVO

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing of vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model. In addition, it offers specialized virology and immunology laboratory, whic... [Read more]

Industry Biotechnology
Sector Healthcare
CEO Dr. Yamin Mohammed Khan Ph.D.
Country United Kingdom
Stock Exchange Euronext Dublin
Ticker Symbol HVO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.